Budesonide/formoterol vs budesonide vs formoterol in patients with mild-to-moderate asthma with or without fixed airway obstruction

Trial Profile

Budesonide/formoterol vs budesonide vs formoterol in patients with mild-to-moderate asthma with or without fixed airway obstruction

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2013

At a glance

  • Drugs Budesonide; Budesonide/formoterol; Formoterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms SPRUCE 80/4.5
  • Sponsors AstraZeneca
  • Most Recent Events

    • 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
    • 15 Mar 2012 New trial record
    • 06 Mar 2012 Results assessing efficacy in patients with versus without fixed airflow obstruction presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top